Science & Enterprise subscription

Follow us on Twitter

  • A mobile and computer app that alerts older citizens about a class of drugs associated with Alzheimer's disease wil… https://t.co/ayTyKvff5T
    about 12 hours ago
  • New post on Science and Enterprise: Trial to Test App Alerting for Dementia-Linked Drugs https://t.co/N6RksAetEY #Science #Business
    about 12 hours ago
  • First results from a clinical trial show a combination of immunotherapies extends survival among patients with mela… https://t.co/K0InhxLxaA
    about 17 hours ago
  • New post on Science and Enterprise: Trial Shows Immunotherapies Extend Life with Melanoma https://t.co/aJPRxRWQNE #Science #Business
    about 17 hours ago
  • The world's five leading technology enterprises are acquiring more companies and with more money in recent years th… https://t.co/mH9F5msWAY
    about 3 days ago

Please share Science & Enterprise

Imaging Technique Captures RNA Viral Infections in Progress

Viral filament protein and RNA

A super-resolution optical image of a single viral protein filament, in red, with viral RNA, in green (Eric Alonas and Philip Santangelo, Georgia Institute of Technology)

Researchers at Georgia Institute of Technology and Emory University in Atlanta, and Vanderbilt University in Nashville devised a method with advanced microscopy to follow the process of viral infections without affecting the virus or its host. The team led by Georgia Tech biomedical engineering professor Philip Santangelo appeared online yesterday in the journal ACS Nano (paid subscription required).

The research team employed a technique known as  direct stochastic optical reconstruction microscopy or dSTORM that provides color and three-dimensional imaging to a resolution of 20 nanometers. For this study, the team used a device from Vutara Inc. in Salt Lake City.

Santangelo and colleagues studied the structure of human respiratory syncytial virus particles as they infect living cells. Respiratory syncytial virus affects mainly infants, and is the most common cause of bronchitis and pneumonia in children under 1 year of age in the U.S. This virus, say the researchers, can be difficult to study, because it can take multiple forms and has a disordered structure.

The respiratory syncytial virus also uses ribonucleic acid or RNA as its viral material to infect healthy host cells, which adds to the complexity because the virus can insert RNA at more than one point in the host cell. The RNA, however, provided the vehicle for tracking the viruses as they infect the hosts.

The team adapted a technique that attaches fluorescent chemical probes to RNA in cells. The technique combines short DNA and RNA strands with the fluorescent chemicals to become a protein that binds to the nucleic acid molecules. The double-genetic nature of the chemical compound, say the researchers, makes it possible for the probes to evade the cells’ defenses.

With these fluorescent markers, the researchers could use a super high-resolution microscope to track  and measure the infection in progress. The researchers were able to capture and measure activity of individual viral particles during the initial infections and replication of viruses within individual cells over an eight hour period.

The team had another challenge in following the infection process: living cells move around. A Georgia Tech colleague, Thomas Barker, devised a technique with fibronectin, a protein that binds cell surfaces including those on DNA, to keep the cells being tracked within a 50 micron range — one micron equals one millionth of a meter.

Santangelo and colleagues believe the technology can be applied to other viruses that use RNA in their infection processes, such as influenza and Ebola. In addition, the technique can also be used to better understand why some cells become infected and others escape infection. “If we can figure out why some cells are exploding with virus while others are not,” says Santangelo in a university statement, “perhaps we can figure out a way to help the bad ones look more like the good ones.”

Read more:

*     *     *

Comments are closed.